Daily Current Affairs for UPSC Civil Services Exam – 22 April 2021

In Today’s News:

  1. Remdesivir

1. Remdesivir

News Summary

In the wake of COVID second wave, Remdesivir is mentioned in the news almost daily.

Prelims GS – Governance(Health)

  • Remdesivir injection is used to treat coronavirus disease 2019 (COVID-19 infection) caused by the SARS-CoV-2 virus in hospitalized adults and children 12 years of age and older who weigh at least 88 pounds (40 kg).
  • Remdesivir is in a class of medications called antivirals.
  • It works by stopping the virus from spreading in the body.
  • Remdesivir is an intravenous nucleotide prodrug of an adenosine analog.
  • Remdesivir binds to the viral RNA-dependent RNA polymerase and inhibits viral replication through premature termination of RNA transcription.
  • It has demonstrated in vitro activity against SARS-CoV-2.
  • Remdesivir is approved by the Food and Drug Administration (FDA) for the treatment of COVID-19

Courtesy: and click here to view another Courtesy official website of the National Institute of Health, USA.



Click here for Daily current affairs for the UPSC exams on other dates.